SYMPOSIA
S70. The Role of Psychiatrists in the Prevention of Violence at the Level of Nations, Communities, and Individuals
1. Violence and Schizophrenia: Therapeutic Variations and Different Societal Influences Result in Variable Expression Between the U.S.A. and Other Countries Peter F. Buckley, M.D.
2. Public Mental Health and Violence: Links, Challenges, and Solutions Dinesh Bhugra, M.B.B.S, Ph.D.
3. Building an Alliance for a Safer Future: A Public Health Approach to Addressing Violence and Reducing Health Inequalities in Scottish Society Denise Coia, M.D.
4. Violence and Mental Illness: Putting Theory Into Practice in a Local Community Sue Bailey, M.D.
S71. Updates on Reproductive Issues in Women’s Mental Health
1. Violence Against Women and Promoting Mental Health Helen E. Herrman, M.D., M.B.
2. Abortion Trauma: Deconstructing the Myth Nada L. Stotland, M.D., M.P.H.
3. Emotional Aspects of Assisted Reproductive Technology Malkah T. Notman, M.D.
4. Decision Making Regarding Psychopharmacology in Pregnancy and Postpartum Gail E. Robinson, M.D.
5. Therapeutic Management, Psych-otropic Medication, and the Postpartum Gisele Apter, M.D., Ph.D.
S72. The Changing Face of Terrorism
1. Mothers of the Mujahideen: Why They Kill Farhana Qazi, M.A.
2. The Smarter Bomb: Women and Children in Palestinian Terrorism Anat Berko, Ph.D.
3. Trauma and Vulnerability to Extremist Violence Schuyler W. Henderson, M.D., M.P.H.
4. Lone Wolves, Radicalization Online, and the Virtual Community of Hatred Jerrold M. Post, M.D.
5. Walking Away: The Disengagement and De-Radicalization of Terrorists John G. Horgan, Ph.D.
6. Preventing Terrorist Recruitment Through Promoting Family and Community Resilience in Muslim Diasporas Stevan Weine, M.D.
S73. Complementary and Alternative Medicine Relevant to Psychiatry
1. Complementary and Alternative Medicine: Integrative Health Care for Psychiatry and Neurology Nisha N. Money, M.D.
2. Medical Acupuncture’s New Potential in Psychological Health Joseph M. Helms, M.D.
3. Treating Pain and PTSD With Acupuncture Robert L. Koffman, M.D., M.P.H.
4. The Therapeutic Use of Animals in Medicine and Psychiatry Elspeth C. Ritchie, M.D., M.P.H.
S74. Research Advances in Psychiatric Pharmacogenomics
1. Personalized Treatment of Bipolar Disorder: Advances in the Pharma cogenetics of Lithium Response John R. Kelsoe, M.D.
2. Progress Toward Use of Pharmacogenetic Information to Avoid Antipsychotic-Induced Tardive Dyskinesia and Weight Gain James L. Kennedy, M.D.
3. Pharmacogenomics in the Search for New ADHD Treatment Targets James T. McCracken, M.D.
4. Increasing the Precision of the Pharmacogenomic Prediction of Anti-depressant Response David A. Mrazek, M.D.
S75. Developments in Forensic Psychiatry in the United States and France: Vive La Difference!
1. A New Law for Psychiatric Treatment in France: First Impressions After Nine Months Francois C. Petitjean, M.D.
2. Outlier Commitment Groups Carl P. Malmquist, M.D.
3. Data on Involuntary Psychiatric Hospitalizations in France Prior to the July 2011 Law Raphael Gourevitch, M.D., Ph.D.
4. Mental Health Law Reform in the United States Richard J. Bonnie, J.D.
5. What Do We Know About Compulsory Community Treatment? Marc Antoine Crocq, M.D.
6. Compare and Contrast the New French Civil Commitment Law With Civil Commitment Practices in the United States J effrey Janofsky, M.D.
S76 Genetic and Epigenetic Factors in Suicidal Behavior: Effects of Early and Late Environmental Stressors
1. Developmental Vulnerability to Suicidal Behavior Philippe Courtet, M.D., Ph.D.
2. The Role of Life Events in Precipitating Suicide Attempts and Completed Suicide Mercedes P. Rodriguez, M.D., Ph.D.
3. Epigenetic Regulation of Genes Involved in Stress Response by Early-Life Adversity: Implications on Suicide Risk Gustavo Turecki, M.D., Ph.D.
4. A Prospective Study of the Role of Life Events in Precipitating Suicidal Behavior Maria A. Oquendo, M.D.
S77. Moral Treatment to Recovery: The Ivy League Hospitals Look at Contemporary Ethical Issues in Psychiatry
1. A Historic Overview of the Inception of Moral Treatment David S. Roby, M.D.
2. Confidentiality of Mental Health Records After Death Patricia R. Recupero, M.D., J.D.
3. Distinctive Competencies Frederick W. Engstrom, M.D.
4. Safe and Satisfied Patients, Circa 2012 Philip J. Wilner, M.D.
5. Superintendent of the Asylum to Recovery Coach: The Psychiatrist’s Role Virginia L. Susman, M.D.
S78. Personalized Medicine: An Update U.S. National Institute on Alcohol Abuse and Alcoholism
1. The Role of Pharmacogenetics in Treating Alcohol Dependence With Ondansetron Bankole A. Johnson, M.D., Ph.D.
2. SSRIs: Widely Prescribed Medications That May Adversely Affect a Subgroup of Alcoholics Henry R. Kranzler, M.D.
3. Alcohol Dependence and Personalized Medicine: Leveraging Neurobiological Phenotypes to Uncover Genetic Predictors Kent Hutchinson, M.D.
4. Functional Polymorphism of the Mu Opioid Receptor Gene (OPRM1) Influences Reinforcement Learning in Humans Elliot Stein, Ph.D.
S79. American Psychiatry and Human Rights in the 21st Century: Services to Special Populations American Association for Social Psychiatry
1. Human Rights and Racial/Ethnic Disparities Andres J. Pumariega, M.D.
2. Human Rights and Mental Health of Women Beverly J. Fauman, M.D.
3. Human Rights and Services to Special Populations: Children and Youth Consuelo C. Cagande, M.D.
4. Addressing Health Disparities in Immigrant and Refugee Children in the United States Eugenio M. Rothe, M.D.
S80. Update in HIV and AIDS Psychiatry Academy of Psychosomatic Medicine
1. HIV Through the Life Cycle: Childhood, Adolescence, and Reproductive Health Suad Kapetanovic, M.D.
2. HIV Through the Life Cycle: Aging of HIV Population Adriana Carvalhal, M.D., Ph.D.
3. Update in HIV and AIDS Psychiatry: Psychopharmacologic Approaches to Care Kelly L. Cozza, M.D.
4. Psychiatric Disorders Jordi Blanch, Ph.D.
5. Multimorbid Medical Illness: Non-HIV and HIV-Related Joseph Z. Lux, M.D.
6. Update in HIV and AIDS Psychiatry: Palliative and End-of-Life Care H arold W. Goforth, M.D.
S81. Improving Quality of Care for Patients With Psychiatric Illness: Combining and Integrating Psycho-pharmacological, Individual, and Family Therapy
1. Combining Pharmacotherapy With Other Modalities Alan F. Schatzberg, M.D.
2. Combining Individual Therapy With Other Modalities Glen O. Gab-bard, M.D.
3. Family Intervention by Psychiatrists as a Routine Component of Patient Care Gabor I. Keitner, M.D.
S82. Integrated Care and the Future of Psychiatry: Teaching Psychiatry Residents and Fellows to Work at the Interface of Mental Health and Primary Care American Association of Directors of Psychiatric Residency Training
1. Training Challenges for Residents in Psychosomatic Medicine Posed by New Models of Health Care Delivery: Integrated Care and the “Medical Home” Marshall Forstein, M.D.
2. Training Challenges for Residents and Fellows in Psychosomatic Medicine Posed by New Models of Health Care Delivery: Integrated Care and the “Medical Home” Robert C. Joseph, M.D., M.S.
3. Mental Health Integration in a Pediatric Primary Care Clinic: Providing Care and Cross-Training Pediatric and Child Psychiatry Residents Emily Frosch, M.D.
4. Impact of Integrated Psychiatry-Primary Medical Care Training on Resident Comfort With General Medical Concerns in Patients With Mental Disorders Kristen Snyder, M.D.
5. Integrated Care and the Future of Psychiatry: Educating Psychiatrists to Work at the Interface of Mental Health and Primary Care Jaesu Han, M.D.
6. Using an Elective Rotation in an Integrated Care Program to Foster Development of Resident Psychiatrist Consulting Skills Anna Ratzliff, M.D., Ph.D.
S83. Assessment of Substance Use Disorder Patient Outcomes Based on Longitudinal Registry/EMR Data U.S. National Institute on Drug Abuse
1. Overview of Methodologies Used to Assess Large Registry Databases Donald Stablein, Ph.D.
2. Substance Use Disorders and Comorbid Psychiatric Disorders Among Young Psychiatric Patients: Findings From a Large Electronic Health Records Database Li-Tzy Wu, D.Sc., M.A.
3. Presentation of European and Australian Cohorts That Assess the Risk and Associated Influences on Mortality During and After Opioid Treatments Matt Hickman, M.Sc., Ph.D.
4. Presentation of EMR System in Italy and Outcome Studies Using Its Data Roberto Mollica, M.D.
5. Using National VA Patient Databases and Registries to Evaluate Care and Outcomes for Patients With Mental and Substance Use Disorders Frederic Blow, Ph.D.
S84. Mentalizing: Current Core Concepts
1. Mentalizing: Current Key Constructs Howard E. Book, M.D.
2. How Mentalization Contributes to Good Psychiatric Management John G. Gunderson, M.D.
3. A Role for Mentalizing in Psychiatric and Medical Education Jon J. Hunter, M.D.
4. Generic Mentalization-Based Interventions: How to Foster a Mentalizing Stance in Your Patients Patrick Luyten, Ph.D.
S85. Psychosocial Treatments for Pediatric Bipolar Disorder: Improving the Prognosis Beyond Medications
1. Anything Besides Medication? An Overview of Alternatives to Pharmaco-therapy in the Treatment of Pediatric Bipolar Disorder Darryl C. Smith, M.D., M.P.H.
2. The Assessment of Children and Adolescents With Bipolar Disorder Eric A. Youngstrom, Ph.D.
3. Functional Impairment, Stress, and Psychosocial Intervention in Bipolar Disorder David J. Miklowitz, Ph.D.
4. A Child and Family-Focused CBT for Pediatric Bipolar Disorder: Development and Preliminary Results Sally Weinstein, Ph.D.